Celldex Therapeutics
CLDX
#4622
Rank
HK$16.88 B
Marketcap
HK$214.94
Share price
-1.93%
Change (1 day)
6.56%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2026 (TTM): -HK$33.97

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$34.10. In 2025 the company made an earnings per share (EPS) of -HK$30.49 a decrease over its 2024 EPS that were of -HK$19.21.

EPS history for Celldex Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$33.9711.41%
2025-HK$30.4958.78%
2024-HK$19.21
2022-HK$18.7345.73%
2021-HK$12.86-23.36%
2020-HK$16.78-41.05%
2019-HK$28.46-76.95%
2018-HK$123.46
2016-HK$148.15-3.82%
2015-HK$154.03-0.76%
2014-HK$155.21
2012-HK$119.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.57-116.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$136.24-499.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.56-166.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-HK$34.41 0.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-HK$31.43-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$15.83-146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-HK$39.51 15.86%๐Ÿ‡บ๐Ÿ‡ธ USA